0001209191-20-015796.txt : 20200303
0001209191-20-015796.hdr.sgml : 20200303
20200303202545
ACCESSION NUMBER: 0001209191-20-015796
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200228
FILED AS OF DATE: 20200303
DATE AS OF CHANGE: 20200303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gonyer David A
CENTRAL INDEX KEY: 0001578768
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36075
FILM NUMBER: 20685273
MAIL ADDRESS:
STREET 1: C/O EVOKE PHARMA, INC.
STREET 2: 505 LOMAS SANTA FE DRIVE
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evoke Pharma Inc
CENTRAL INDEX KEY: 0001403708
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208447886
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 420 STEVENS AVENUE
STREET 2: SUITE 370
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
BUSINESS PHONE: 858-345-1494
MAIL ADDRESS:
STREET 1: 420 STEVENS AVENUE
STREET 2: SUITE 370
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-28
0
0001403708
Evoke Pharma Inc
EVOK
0001578768
Gonyer David A
C/O EVOKE PHARMA, INC.
420 STEVENS AVENUE, SUITE 370
SOLANA BEACH
CA
92075
0
1
0
0
President and CEO
Stock Option (Right to Buy)
1.23
2020-02-28
4
A
0
325000
0.00
A
2030-02-27
Common Stock
325000
325000
D
One-half of the stock options will vest in 48 equal monthly installments over the four-year period beginning on January 1, 2020, subject to the reporting person's continued service to the issuer through each such vesting date. The other one-half of the stock options will vest in 48 equal monthly installments over the four-year period beginning on the date, if any, on which the U.S. Food and Drug Administration approves the Issuer's new drug application for Gimoti, subject to the reporting person's continued service to the issuer through each such vesting date.
/s/ Matthew J. D'Onofrio, Attorney-in-fact for David A. Gonyer
2020-03-03